134 related articles for article (PubMed ID: 34607062)
1. Bacterial bloodstream infections and patterns of resistance in patients with haematological malignancies at a tertiary centre in Lebanon over 10 years.
Haddad S; Jabbour JF; Hindy JR; Makki M; Sabbagh A; Nayfeh M; Boustany M; El-Zein S; Tamim H; Zakhem AE; El Cheikh J; Bazarbachi A; Kanj SS
J Glob Antimicrob Resist; 2021 Dec; 27():228-235. PubMed ID: 34607062
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
Int J Antimicrob Agents; 2023 Jun; 61(6):106806. PubMed ID: 37030470
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections in neutropenic patients with haematological malignancies.
Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
[TBL] [Abstract][Full Text] [Related]
8. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
[TBL] [Abstract][Full Text] [Related]
9. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years.
Peri AM; Edwards F; Henden A; Harris PNA; Chatfield MD; Paterson DL; Laupland KB
Clin Exp Med; 2023 Dec; 23(8):4563-4573. PubMed ID: 37815735
[TBL] [Abstract][Full Text] [Related]
11. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study.
Mimura W; Fukuda H; Akazawa M
Ann Clin Microbiol Antimicrob; 2020 Feb; 19(1):7. PubMed ID: 32066448
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Litwin A; Fedorowicz O; Duszynska W
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
[No Abstract] [Full Text] [Related]
14. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
[TBL] [Abstract][Full Text] [Related]
15. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
[TBL] [Abstract][Full Text] [Related]
16. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
[TBL] [Abstract][Full Text] [Related]
18. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
Giammanco A; Calà C; Fasciana T; Dowzicky MJ
mSphere; 2017; 2(1):. PubMed ID: 28124025
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk factors for recurrence in biliary source bloodstream infection episodes in oncological patients.
Grafia I; Chumbita M; Seguí E; Cardozo C; Laguna JC; García de Herreros M; Garcia-Pouton N; Villaescusa A; Pitart C; Rico-Caballero V; Marco-Hernández J; Zamora C; Viladot M; Padrosa J; Tuca A; Mayor-Vázquez E; Marco F; Martínez JA; Mensa J; Garcia-Vidal C; Soriano A; Puerta-Alcalde P
Microbiol Spectr; 2023 Aug; 11(5):e0214223. PubMed ID: 37610217
[TBL] [Abstract][Full Text] [Related]
20. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
